Agere Pharmaceuticals, Inc. Release: Solubilization Formulations Using Polyvinyl Acetate Phthalate (PVAP) as a Dispersion Polymer
Published: Apr 16, 2013
BEND, Ore.--(BUSINESS WIRE)--Agere Pharmaceuticals, Inc., a leading oral bioavailability contract research and manufacturing organization (CRMO), announced today that it will present case studies on spray drying of poorly soluble Active Pharmaceutical Ingredients (APIs) utilizing PVAP as a dispersion polymer excipient for enhancing bioavailability. The presentation will be made in conjunction with BUCHI Corporation as part of an interactive webinar focusing on current trends in laboratory spray drying. The event is sponsored by American Pharmaceutical Review, the leading review journal for business and technology in the pharmaceutical industry throughout North America.